In vitro chondrogenic potency of surplus chondrocytes from autologous transplantation procedures does not predict short-term clinical outcomes

BACKGROUND: Autologous chondrocyte implantation (ACI) has been used over the last two decades to treat focal cartilage lesions aiming to delay or prevent the onset of osteoarthritis; however, some patients do not respond adequately to the procedure. A number of biomarkers that can forecast the clini...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:BMC Musculoskelet Disord
Auteurs principaux: Islam, Ashraful, Fossum, Vegard, Hansen, Ann Kristin, Urbarova, Ilona, Knutsen, Gunnar, Martinez-Zubiaurre, Inigo
Format: Artigo
Langue:Inglês
Publié: BioMed Central 2019
Sujets:
Research Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6329094/
https://ncbi.nlm.nih.gov/pubmed/30630436
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12891-018-2380-4
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires